title: Delayed life-threatening pneumonitis secondary to procarbazine.
abstract: A patient with advanced Hodgkin's disease being treated with MOPP chemotherapy presented with delayed life-threatening pulmonary toxicity secondary to procarbazine. The pulmonary toxicity began 1 week after procarbazine had been discontinued and once recognized was successfully treated with intravenous steroids.
authors.affiliation: Ochsner Clinic of Baton Rouge, Louisiana 70816.
authors.forename: B J
authors.initials: BJ
authors.lastname: Brooks
authors.forename: N B
authors.initials: NB
authors.lastname: Hendler
authors.forename: S
authors.initials: S
authors.lastname: Alvarez
authors.forename: N
authors.initials: N
authors.lastname: Ancalmo
authors.forename: S F
authors.initials: SF
authors.lastname: Grinton
mesh_terms: D000328:Adult; D000542:Alveolitis, Extrinsic Allergic / Q000139:chemically induced* / Q000175:diagnosis; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D003937:Diagnosis, Differential; D004334:Drug Administration Schedule; D004342:Drug Hypersensitivity / Q000209:etiology; D005260:Female; D006689:Hodgkin Disease / Q000188:drug therapy*; D006801:Humans; D007877:Legionnaires' Disease / Q000175:diagnosis; D008466:Mechlorethamine / Q000008:administration & dosage; D011020:Pneumonia, Pneumocystis / Q000175:diagnosis; D011241:Prednisone / Q000008:administration & dosage; D011344:Procarbazine / Q000008:administration & dosage / Q000009:adverse effects*; D014750:Vincristine / Q000008:administration & dosage
chemical_list: D011344:Procarbazine; D008466:Mechlorethamine; D014750:Vincristine; D011241:Prednisone